Featured resources
Reduce the risk of future complications
In addition to screening for TB at the onset of immunotherapy, retesting every 1–2 years for patients who have a new or recurring risk factor should be considered. Risk factors include living in or extended travel to an endemic country, TB exposure, or employment in a healthcare or congregate setting. Risk factors such as smoking, substance use disorders, diabetes, etc. should also be considered.
Avant d’initier un traitement par inhibiteur du TNF-α, faites confiance au QFT-Plus pour une détection précise de la tuberculose.
Pour plus d’informations, contactez votre représentant commercial QIAGEN.
Références :